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586Objectives: Bilateral internal thoracic artery (BITA) grafting in patients with diabetes are controversial because
of increased risk of sternal infection. On the other hand, patients with diabetes may benefit from BITA grafts
because of the associated improved survival. This study evaluated factors affecting early and long-term out-
comes for better selection of patients with diabetes for BITA grafts.
Methods:Between 1996 and 2006, 69 patients with insulin-treated diabetes and 732 with orally treated diabetes
received isolated skeletonized BITA grafts. Of these patients, 338 were younger than 65 years, 322 were between
65 and 74 years old, and 141 were 75 years or older.
Results:Operativemortality was lower than logistic EuroSCORE–calculated mortality (2.9% vs 7%, P<.001).
Predictors of increased mortality were critical preoperative state (P<.001) and age (P ¼ .008). There were 30
cases of sternal infection (3.7%); predictors were reoperation (P<.001), peripheral vascular disease (P¼ .009),
obesity (P ¼ .012), chronic lung disease (P ¼ .009), and female sex (P ¼ .020). Mean follow-up was 8.4  4
years. Kaplan-Meier 10-year survivals were 75%, 59%, and 39% for patients younger than 65, 65 to 74, and at
least 75 years, respectively (P<.001). They were better than corresponding Charlson comorbidity index–pre-
dicted survivals (36%, 10%, and 3%, respectively; P< .001). Predictors of decreased survival were age
(P<.001), congestive heart failure (P<.001), and peripheral vascular disease (P<.001). Off-pump surgery
was independently associated with better long-term survival (P ¼ .003).
Conclusions: BITA grafts are safe in patients with diabetes. Favorable short- and long-term outcomes outweigh
increased sternal infection risk. (J Thorac Cardiovasc Surg 2013;146:586-92)Ischemic heart disease is the leading cause of death in pa-
tients with diabetes mellitus.1 Patients with diabetes have
a tendency toward development of multivessel disease,
and their prognosis is worse than that of patients without di-
abetes. More and more patients with diabetes are being re-
ferred for coronary artery bypass grafting (CABG) or for
angioplasty for revascularization of the coronary system,2
which makes them a large proportion of the patients under-
going these procedures.3
Surgical revascularization of the left anterior descending
artery with the internal thoracic artery (ITA) is still the only
proven method of improving event-free survival in patients
with multivessel disease.4,5 Long-term follow-up of the By-
pass Angioplasty Revascularization Investigation study
showed that in patients diabetes with multivessel disease,e Departments of Cardiothoracic Surgery,a Tel Aviv Sourasky Medical Cen-
l Aviv, Israel; the Department of Cardiothoracic Surgery,b Sackler School of
cine, Tel Aviv University, Tel Aviv, Israel; and the Department of Cardiotho-
Surgery,c Beilinson Medical Center, Petah Tikva, Israel.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Jan 23, 2012; revisions received March 22, 2012; accepted
blication April 6, 2012; available ahead of print Aug 23, 2012.
for reprints: Rephael Mohr, MD, Department of Cardiothoracic Surgery, Tel
Sourasky Medical Center, 6 Weizman St, Tel Aviv 64239, Israel (E-mail:
n@tasmc.health.gov.il).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.04.024
The Journal of Thoracic and Cardiovascular SurgCABG was associated with significantly lower rates of sud-
den death and myocardial infarction–related death6 than
was angioplasty. Left anterior descending revascularization
in that study was an independent predictor of long-term
survival.
Similar findings were reported later in the Arterial Revas-
cularization Therapy study.7 In that study, the 3-year sur-
vival of patients with diabetes undergoing CABG was
higher than that of patients with diabetes undergoing coro-
nary angioplasty with bare-metal stents.
Bilateral ITA (BITA) grafting is associated with im-
proved survival relative to CABG with single ITA grafts
and saphenous vein grafts (SVGs).7 In addition to im-
proved survival, patients with BITA had better event-free
survival and reduced occurrence of reinterventions.7 De-
spite the improved long-term outcomes in patients without
diabetes, the application of this technique in those with di-
abetes remains controversial because of the increased risk
of sternal infection and subsequent lethal mediastinitis as
a result of sternal devascularization.8 Collateral circulation
to the sternum can be partially preserved if the conduit is
harvested as a skeletonized conduit.9 Dividing the collat-
eral branches with hemostatic clips and scissors enables
maintenance of collateral perfusion from the intercostal
or the muscular branches, which are usually destroyed
by the use of the cautery and the dissection of the conduit
as a pedicle.ery c September 2013
Abbreviations and Acronyms
BITA ¼ bilateral internal thoracic artery
CABG ¼ coronary artery bypass grafting
CCI ¼ Charlson comorbidity index
CI ¼ confidence interval
COPD ¼ chronic obstructive pulmonary disease
HR ¼ hazard ratio
ITA ¼ internal thoracic artery
OPCAB ¼ off-pump coronary artery bypass
grafting
OR ¼ odds ratio
PVD ¼ peripheral vascular disease
RCA ¼ right coronary artery
SVG ¼ saphenous vein graft
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days after the operation can also form the basis for im-
proved sternal wound healing in patients with diabetes9;
in our experience, however, occurrence of sternal wound in-
fection was still higher in patients with diabetes than in
those without, and diabetes has been found to be a signifi-
cant predictor of sternal wound infection in multivariable
logistic regression analysis.10 Despite the increased risk
of sternal complications, patients with diabetes may still
benefit from BITA grafting because of their accelerated ath-
erosclerosis and the increased propensity toward SVG
failure.4,11
The purpose of this study was to evaluate early and long-
term outcomes of skeletonized BITA grafting in patients
with diabetes to determine whether potential survival bene-
fit outweighs the increased risk of sternal infection. We also
wished to evaluate preoperative and operative factors af-
fecting early and long-term outcomes to improve selection
of patients with diabetes to receive BITA grafts.MATERIALS AND METHODS
From January 1996 to December 2006, a total of 801 consecutive pa-
tients with diabetes underwent myocardial revascularization with BITAs
that were dissected as skeletonized arteries.9 They comprised 30.6% of
the 2615 isolated BITA grafting procedures performed in the Tel Aviv
Sourasky Medical Center during this time. Preoperative and operative pa-
tient data were collected from the hospital medical records with institu-
tional review board approval. To evaluate the effects of age on early and
long-term outcomes, patients were stratified into 3 age groups: 64 years
old or younger, between 65 and 74 years old, and 75 years or older. To eval-
uate the learning curve effect, patients were stratified according to their op-
erative date into 2 groups: early (1996-1999) and late (2000-2006).
Expected operative mortality was calculated with the logistic Euro-
SCORE12 and compared with the observed early mortality. Expected mid-
term and long-term mortalities without operation were calculated with the
Charlson comorbidity index (CCI)13 and compared with the expected sur-
vival of the Israeli population of the same age and sex distribution14 and
with the Kaplan-Meier actuarial survival. Follow-up was obtained with
the Israeli National Registry database and a telephone questionnaire.The Journal of Thoracic and CaSurgical Techniques
Operations were performedwith standard cardiopulmonary bypass or as
off-pump CABG (OPCAB). Myocardial preservation during cardiopulmo-
nary bypass involved intermittent, antegrade or retrograde blood cardiople-
gia (30C-32C). Coronary stabilization during OPCAB was facilitated
with CTS stabilizers (Guidant, Indianapolis, Ind) or the Octopus system
(Medtronic, Minneapolis, Minn). ITAs were mobilized from the chest
wall as skeletonized vessels.9,15 In most cases, BITAs were used to graft
the left coronary system, the myocardial territory supplied by the left
anterior descending and circumflex arteries. Two arrangements were
implemented: a free right ITA attached proximally end to side on the left
ITA in a T-graft configuration (composite T-graft) and an in situ BITA
with an anteaortic crossover right ITA. The choice of configuration was
determined by previously detailed technical considerations.15 The type
of conduit selected for right coronary artery (RCA) grafting was not related
to the configuration of the ITAs. Our strategy was to use right ITAs, right
gastroepiploic arteries, and radial arteries as grafts to the RCA branches
only in the presence of a significant stenosis (>80%).16When the RCA sys-
temwas unsuitable for arterial grafting, such as in cases with a potential for
high competitive flow in the RCA, we selected SVG as the conduit for re-
vascularization of the RCA.
To decrease the risk of spasm of the arterial grafts, all patients were
treated with a high-dose intravenous infusion of isosorbide dinitrate (Iso-
ket; 4-20 mg/h) during the first 48 postoperative hours. Calcium-channel
blockers (diltiazem hydrochloride [INN diltiazem]; 90-180 mg/d orally)
were given to patients operated on using right gastroepiploic artery or radial
artery from the second postoperative day for at least 3 months.15Definition of Terms and Data Collection
Patient data were analyzed according to American College of Cardiol-
ogy and American Heart Association Clinical Data Standards.17
Chronic renal failure was diagnosed if the creatinine level exceeded 1.8
mg/dL. Peripheral vascular disease (PVD) included all symptomatic and
asymptomatic extracoronary arteriopathy. Cerebrovascular disease in-
cluded history of any previous cerebrovascular event, with or without per-
manent neurologic damage.
Our definition of an emergency operation was based on the Society of
Thoracic Surgeons guidelines and included patients operated on within
24 hours of cardiac catheterization, with ongoing angina, acute evolving
myocardial infarction, pulmonary edema, or cardiogenic shock.18 Pa-
tients who needed emergency surgery and were not stabilized after
intra-aortic balloon counterpulsation were usually operated on with a sin-
gle ITA combined with SVGs and therefore were not included. A perio-
perative myocardial infarction was defined by the appearance of new
Q waves in the electrocardiogram associated with elevated levels of cre-
atine kinase MB fraction (>50 mU/mL). A cerebrovascular accident was
defined as a new permanent neurologic deficit with computed tomo-
graphic evidence of cerebral infarction. Deep sternal infection was
defined as the sum of deep infection and late dehiscence requiring
sternectomy.Statistical Analysis
Data are expressed as the mean SD or as a proportion. The c2 test and
2-sample t tests were used to compare discrete and continuous variables,
respectively. Multivariable logistic regression analysis was used to predict
early mortality and early morbidity events by various risk factors. The odds
ratios (ORs) with 95% confidence intervals (CIs) are given. Postoperative
survivals of each age group are expressed by the Kaplan-Meier method, and
survival curves were compared with the log-rank test. The Cox propor-
tional hazard model was used to evaluate the influence of preoperative vari-
ables and operative data on late and overall mortalities. A Cox model was
used to compare adjusted survivals between the various age groups after
controlling for differences between groups in preoperative and operativerdiovascular Surgery c Volume 146, Number 3 587
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Dcharacteristics. Results of Cox analysis are expressed as hazard ratios
(HRs) with 95% CIs.
To present the expected annual survival of the general population on the
basis of our sample of patients, we used the 2005 through 2009 complete
life tables published by the Israeli National Central Bureau of Statistics14
to calculate the annual survival for each patient according to age and sex
out to 15 years. In addition, we used the CCI formulation to calculate the
expected 10-year survivals of our patients assuming no surgery was per-
formed. The CCI formulation estimates survival of people according their
age and certain comorbidities. It has been validated for 10-year survival.13
For presentation purpose only, we extended the CCI formulation principle
to calculate the estimated annual survival of each patient according to age
and CCI out to 15 years. The CCI formulation uses a 10-year survival of
a 40-year-old person with no comorbidities (98%) as the baseline survival
for its calculations. We used the relative annual survival of a 40-year-old
person taken from the Israeli complete life tables14 as the baseline survival
to calculate the annual estimated survival of each patient without surgery.
Because the CCI formulation has been validated for 10-year survival only,
we performed formal statistical comparison of survival between the ex-
pected general population survival, observed actuarial survival, and esti-
mated survival of the patients if no operation had been performed only at
10 years with a 1-sample t test.
Statistical analysis was performed with SPSS for Windows version 19
(IBM Corporation, Armonk, NY).TABLE 1. Patient characteristics and early mortality (N ¼ 23)
Risk factor
Prevalence of risk factor Mo
N %
Age<65 y 338 42.2
Age 65-74 y 322 40.2
Age 75 y 141 17.6
Female 200 25
Type 1 diabetes 69 8.6
COPD 39 4.9
Congestive heart failure 205 25.6
Chronic renal failure 68 8.5
PVD 202 25.2
RCA revascularization 489 61
Hypertension 508 63
Hyperlipidemia 495 62
Acute myocardial infarction (1 wk) 140 17.4
Intra-aortic balloon pump 41 5.1
Old myocardial infarction (>1 wk) 334 41.7
Unstable angina pectoris 454 56.7
Left main disease 209 26
Ejection fraction 30% 60 7.5
Critical preoperative state* 59 7.4
Emergency operation 71 8.9
Reoperation 18 2.2
Triple-vessel disease 644 80.4
Composite T graft 454 56.7
OPCAB 232 29
Bypass grafts (3) 581 72.5
Obesity (BMI  30 kg/m2) 122 15.2
Early period (1996-1999) 320 40
BMI, Body mass index;COPD, chronic obstructive pulmonary disease;OPCAB, off-pump c
artery. *Critical preoperative state includes any of the following: ventricular tachycardia or
ventilation before arrival in the anesthetic room, preoperative inotropic support, intra-aortic
mL/h]).
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The patients’ preoperative characteristics and their rela-
tionships with early postoperative mortality are presented
in Table 1.
The mean number of grafts per patient was 3.04. The ac-
tual early mortality was lower than the logistic Euro-
SCORE–calculated mortality (2.9% vs 7%; P<.001).
Multivariable logistic regression revealed critical preop-
erative state (OR, 9.734; 95% CI, 3.698-25.623) and in-
creased age (OR, 1.078; 95% CI, 1.019-1.132) to be
independently associated with increased operative mortal-
ity. Patients undergoing OPCAB procedures had decreased
operative mortality (Table 1) and significantly lower Cox-
adjusted mortality (OR, 0.263; 95% CI, 0.071-0.976;
P ¼ .046).
Early postoperative morbidity (Table 2) included sternal
infection (3.7%), cerebrovascular accident (2.1%), and
perioperative myocardial infarction (0.4%). Multivariable
correlates of sternal infection were reoperation (OR,
12.432; 95% CI, 3.388-45.64; P < .001), chronicrtality with risk factor Mortality without risk factor
P valueN % N %
3 0.9 20 4.1 .013
15 4.7 8 1.7 .013
5 3.5 18 2.7 .013
8 4 15 2.5 .192
2 2.9 21 2.9 .605
4 10.3 19 2.5 .022
12 5.9 11 1.8 .005
5 7.4 18 2.5 .038
11 5.4 12 2.0 .011
14 2.9 9 2.9 >.999
14 2.8 9 3.1 .477
12 2.4 11 3.6 .335
4 2.9 19 2.9 .626
5 12.2 18 2.4 .005
14 4.2 9 1.9 .058
12 2.6 11 3.2 .658
7 3.3 16 2.7 .871
2 3.3 21 2.8 .526
8 13.6 15 2.0 <.001
4 5.6 19 2.6 .144
1 5.6 21 2.8 .411
23 3.6 0 0 .016
13 2.9 10 2.9 >.999
3 1.3 20 3.5 .088
15 2.6 8 3.6 .425
2 1.6 21 3.1 .318
13 4.1 10 2.1 .078
oronary artery bypass grafting; PVD, peripheral vascular disease; RCA, right coronary
fibrillation, aborted sudden cardiac death, preoperative cardiac massage, preoperative
balloon counterpulsation, and preoperative acute renal failure (anuria or oliguria [<10
ery c September 2013
TABLE 2. Patient characteristics and sternal infection (N ¼ 30)
Risk factor
Prevalence of risk factor Infection with risk factor Infection without risk factor
P valueN % N % N %
Age<65 y 338 42.2 11 3.3 19 4.1 .754
Age 65-74 y 322 42 14 4.3 16 3.3 .754
Age 75 y 141 17.6 5 3.5 25 3.8 .756
Female 200 25 13 6.5 17 2.8 .031
Type 1 diabetes 69 8.6 5 7.2 25 3.4 .107
COPD 39 4.9 5 12.8 25 3.3 .009
Congestive heart failure 205 25.6 12 5.9 18 3.0 .103
Chronic renal failure 68 8.5 6 8.8 24 3.3 .049
PVD 202 25.2 14 6.9 16 2.7 .011
RCA revascularization 489 61 19 3.9 11 3.5 .794
Hypertension 508 63 21 4.1 9 3.1 .569
Hyperlipidemia 495 62 16 3.2 14 4.6 .435
Acute myocardial infarction (1 wk) 140 17.4 5 3.6 25 3.8 .905
Intra-aortic balloon pump 41 5.1 2 4.9 28 3.7 .462
Old myocardial infarction (>3 wk) 334 41.7 15 4.5 15 3.2 .452
Unstable angina pectoris 454 56.7 18 4.0 12 3.5 .852
Left main disease 209 26 10 4.8 20 3.4 .648
Ejection fraction<30% 60 7.5 3 5 27 3.6 .393
Critical preoperative state* 59 7.4 2 3.4 28 3.8 .617
Emergency operation 71 8.9 5 7 25 3.4 .228
Reoperation 18 2.2 4 22 26 3.3 <.001
Triple-vessel disease 644 80.4 29 4.5 1 0.6 .011
Composite T graft 454 56.7 20 4.4 10 2.9 .349
OPCAB 232 29 5 2.2 25 4.4 .191
Bypass grafts (3) 581 72.5 21 3.6 9 4.1 .751
Obesity (BMI  30 kg/m2) 122 15.2 10 8.2 20 3.0 .012
Early period 320 40 20 6.3 10 2.1 .002
BMI, Body mass index;COPD, chronic obstructive pulmonary disease;OPCAB, off-pump coronary artery bypass grafting; PVD, peripheral vascular disease; RCA, right coronary
artery. *Critical preoperative state includes any of the following: ventricular tachycardia or fibrillation, aborted sudden death, preoperative cardiac massage, preoperative ven-
tilation before arrival in the anesthetic room, preoperative inotropic support, intra-aortic balloon counterpulsation, and preoperative acute renal failure (anuria or oliguria [<10
mL/h]).
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1.450-13.820; P < .001), PVD (OR, 2.836; 95% CI,
1.301-6.182; P ¼ .009), obesity (OR, 2.977; 95% CI,
1.273-6.964; P ¼ .012), and female sex (OR, 2.589; 95%
CI, 1.159-5.650; P ¼ .020).
On the basis of early analysis of our sternal infection in
patients with diabetes undergoing CABG with BITA
grafts,19 the use of this surgical technique in the later period
of our study (2000-2006) was more selective. There was
a significant decrease in the prevalence of COPD (6.9%
vs 3.5%; P ¼ .031) and female sex (29.4% vs 22%;
P ¼ .023). More patients in the later period underwent
BITA grafting incorporating the OPCAB technique
(44.3% vs 5.95% in the early period; P ¼ .001).
When the factor of early operative period (1996-1999)
was included in the regression, it was found to be indepen-
dently associated with an increased incidence of sternal in-
fection (OR, 3.115; 95% CI, 1.370-7.092), forcing out
COPD and female sex.
Mean follow-up was 8.4  4 years. The Kaplan-Meier
10-year survivals for patients younger than 65 years,The Journal of Thoracic and Ca65-74 years old, and at least 75 years old were 75%,
59%, and 39%, respectively (P<.001). They were slightly
but significantly lower than the corresponding expected sur-
vivals of the general Israeli population without operation
(Figure 1). When associated comorbidities were included
in calculation of expected survival, however, Kaplan-
Meier 10-year survivals were better than the corresponding
CCI-predicted survivals (36%, 10%, and 3% respectively;
P<.001 for all age groups; Figure 1).
Multivariable (Cox model) predictors of decreased sur-
vival were age (HR, 1.049; 95% CI, 1.035-1.063;
P< .001; Figure 2), congestive heart failure (HR, 2.259;
95% CI, 1.636-2.593; P< .001), and PVD (HR, 1.775;
95% CI, 1.401-2.249; P< .001). OPCAB was indepen-
dently associated with better survival (HR, 0.636; 95%
CI, 0.472-0.859; P ¼ .003; Figure 3). To assess whether
the CCI formulation was indeed associated with survival
in our group of patients, we fitted a Cox regression model
for survival with age and the calculated CCI as covariates.
Both age and CCI turned out to be independent predictors
of survival (P<.001).rdiovascular Surgery c Volume 146, Number 3 589
FIGURE. 1. Charlson comorbidity index–predicted 10-year survival (CCI
expected) versus Israeli population expected 10-year survival (Is. Pop.
Exp.) without operation and observed Kaplan-Meier 10-year survival
(K.M. observed) by age groups. P<.001 for all pairwise comparisons of
each age group. Ages are in years.
FIGURE 3. Long-term adjusted survival (Cox) by operative technique
(off bypass [OPCAB] vs with bypass [CPB]).
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not have any independent effect on survival.
DISCUSSION
The long-term success of CABG is directly related to
graft patency. ITA grafts, because of their resistance to ath-
erosclerosis, have better long-term patency then SVGs, and
this patency of ITA grafts is believed to be responsible for
the increased survival and decreased recurrence of angina
and need for reoperation when they are used to bypass the
left anterior descending coronary artery.5
Use of a single ITA graft in CABG has also been recog-
nized as an independent predictor of improved survival inFIGURE 2. Cox-adjusted survival by age group. Ages are in years.
590 The Journal of Thoracic and Cardiovascular Surgpatients with diabetes.6,20 In the general population, left-
sided BITA grafts are associated with improved survival,
event-free survival, and freedom from repeat revasculariza-
tion relative to single ITA grafts and SVGs7; however, the
application of BITA grafting technique in patients with di-
abetes is controversial because its effect on long-term sur-
vival is questionable as a result of the increased risk of
sternal dehiscence and sternal infection8 caused by the
more extensive devascularization associated with harvest-
ing 2 ITAs21 and in view of the excellent survival benefit ob-
tained with a single ITA graft.
Increased risk of sternal complication was also reported
in the subset of patients with diabetes in our previous pub-
lication describing routine use of BITA grafts in a cohort
of 1515 patients who underwent CABG with skeletonized
BITA grafts in our center between 1996 and 2001.10
The overall risk of sternal complication in this cohort
was 1.9%; however, occurrences of sternal complications
(deep infection and dehiscence) in the patients with type 2
and type 1 diabetes were significantly higher than in pa-
tients without diabetes (2.9%, and 5.9%, respectively, vs
0.8%). Type 2 diabetes (OR, 4.64; 95% CI, 1.85-11.59)
and type 1 diabetes (OR, 6.9; 95% CI, 1.35-35.27) were
also found to be independent predictors of sternal
complications.
A larger cohort of patients with diabetes with longer
follow-up is described in this report. Despite increased oc-
currence of sternal complications in this report (3.4% in the
type 2 subset and 7.2% in the type 1 subset), the observed
hospital mortality (2.9%) was significantly lower than the
EuroSCORE-calculated mortality (7.0%; P<.001).
Moreover, the actual 10-year survivals (Kaplan-Meier)
as well as risk adjusted (Cox) survival estimates areery c September 2013
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predicted 10-year survivals for all age groups (<65, 65-74,
and 75 years), suggesting significant survival benefit of
BITA grafts for all age groups despite the increased risk
of sternal complications.
The CCI is a well-validated tool that divides patients
according to comorbidity severity, which is translated to
survival. It is influenced by several preoperative variables
such as age, cerebrovascular disease, pulmonary disease,
congestive heart failure, myocardial infarction, PVD,
diabetes, renal dysfunction, and several other conditions
that are much rarer and probably less relevant to our study
(such as malignancy).13 The unfavorable predicted sur-
vival without surgery and the improved survival with sur-
gery in this study are not surprising. There is a major
effect of heart disease on survival. Schmidt and co-
workers,13 in a recent nationwide population study of all
hospitals in Denmark, analyzed 234,331 patients with
first-time acute myocardial infarction and found that
even in the current era, those who survive 30 days have
a 6% risk of dying during the first year even if no comor-
bidity exists. If the CCI score is greater, then the risk of
dying during the first year increases to 31%. (The patients
in our study had a mean CCI of 5.)
In an effort to reduce the risk of sternal complications, we
analyzed our early results and became more careful in the
later period with regard to patient selection for BITA grafts,
with especial attention to the risk factors of diabetes,
COPD, reoperation, female sex, and obesity.10,19 The
decreased occurrence of sternal complications in the later
period (2000-2006) may be related to decreased
prevalences of COPD, obesity, and female sex in that
period.
The more liberal use of BITA grafts in patients with type
1 diabetes in the later period was based on Lev-Ran and col-
leagues’ report.22 In that study, occurrence of sternal com-
plications among patients with type 1 diabetes with BITA
was similar to that of patients with type 1 diabetes treated
with single ITA (4% vs 2.7%; P>.999) This policy cannot
be supported by results of our study. Occurrence of 7.2%
sternal complications in the subset of patients with type 1
diabetes cannot be acceptable.
In another study by Lev-Ran and colleagues,23 similar
early outcomes, including similar incidence of sternal infec-
tion, were observed in patients with type 2 diabetes treated
with BITA and single ITA (1.8% in both groups). During
follow-up (4-7.5 years), there were fewer repeated revascu-
larizations (4.4% vs 12.3%; P ¼ .025) and major adverse
events (11.2 % vs 36.8%; P< .001) in the BITA group.
At 7 years, Kaplan- Meier survival (75% vs 59%,
P ¼ .006) and freedom from cardiac-related mortality
(92% vs 68%; P<.001) were superior in the BITA group.
The survival benefit observed in our study, together with re-
sults of Lev-Ran and colleagues’ study,23 support the use ofThe Journal of Thoracic and CaBITA grafts in patients with type 2 diabetes of all age
groups.
The survival benefit observed in our report and the supe-
riority of BITA observed in Lev-Ran and colleagues’ re-
port23 negate results of previous study comparing large
groups of matched patients with diabetes receiving BITA
grafts versus single ITA grafts. This study suggests 5-year
survival benefit of BITA grafts relative to single ITA grafts
only in the subgroups of patients between 60 and 69 years of
age, whereas single ITA grafts were beneficial for patients
older than 79 years.24
An interesting finding of our study was the better long-
term survival of patients with diabetes undergoing CABG
with BITA grafts without extracorporeal circulation (OP-
CAB). In our report, the use of OPCAB was an independent
predictor of better long-term survival in patients with diabe-
tes undergoing CABG with BITA grafts. This was a rela-
tively large cohort (232 patients) of patients with diabetes
undergoing OPCAB with BITA grafts and is the first to
show a survival advantage for this surgical technique in pa-
tients with diabetes. A previous study describing the supe-
riority of OPCAB in patients with diabetes reported only
early outcomes relative to outcomes of patients operated
on with cardiopulmonary bypass.25 In that study, the better
outcome of patients undergoing OPCAB was attributed to
the more common use of arterial conduits. This explanation
is not pertinent to our report, because all patients in our
study underwent left-sided arterial grafting with two
ITAs. A possible explanation for the better survival of
patients undergoing OPCAB might be the routine use of
clopidogrel bisulfate (INN clopidogrel) treatment after
OPCAB procedures. The recommended duration of postop-
erative clopidogrel treatment was only 3 to 6 months, how-
ever, and we do not have complete data on the actual
duration and adherence of patients to this antiplatelet
treatment.
In conclusion, our study suggests that the survival benefit
of BITA grafts for patients with diabetes outweighs the
early adverse effect of sternal wound complications. Occur-
rence of these complications can be reduced by selective
use of BITA grafts in this subset of patients. The study
did not compare long-term results with those of single
ITA grafts; however, its results suggest that to reduce occur-
rence of sternal complications, this technique should not be
applied to patients with COPD, PVD, reoperations, and
obesity (especially female patients). Despite our observa-
tion that type 1 diabetes was not an independent predictor
of sternal complications, we do not recommend routine
use of BITA grafts in patients with type 1 diabetes. When-
ever possible, we advocate the use of OPCAB technique in
patients with diabetes receiving BITA grafts. Age is not
a contraindication for BITA graft use; however, further
studies are required to compare long-term outcomes of
BITA and single ITA grafts in elderly patients with diabetes.rdiovascular Surgery c Volume 146, Number 3 591
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This is a retrospective study, and potential long-term ben-
efits of BITA grafts for patients with diabetes could not be
demonstrated without comparing its outcome with that of
CABG procedures incorporating a single ITA and other
conduits, such as SVGs or radial arteries. Postoperative an-
giograms and coronary computed tomographic angiograms
were available only in a small number of patients, mostly in
symptomatic patients. Therefore, they could not be in-
cluded in this report.
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